(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

KINOMICA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

KINOMICA

ST13

US500000088272871

Classe

1, 5, 9, 42, 44, 45

Pedido

88272871

Registro

6150426

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

16/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 42, 44, 45

Data de depósito

23/01/2019

Data de registro

15/09/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/09/2020

Última transação

16/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Macclesfield, Cheshire, GB

Examinador

TRATOS,MARK STEVEN

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Kinomica Limited
Kinomica Limited

Representantes

Andrew D. Price VENABLE LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 42Classe 44Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Scientific instruments and equipmentdiagnostic assays for measuring and analyzing proteinsenzymesgenes and tumors other than for medical or veterinary use

Classe 5

Scientific instruments and equipmentmedical diagnostic assays for measuring and analyzing proteinsenzymesgenes and tumors

Classe 9

Scientific instruments and equipmentscientific equipment in the nature of mass spectrometers and liquid chromatography equipmentchromatography columns for laboratory use for measuring and analyzing proteinsenzymesgenes and tumors; downloadable databases in the field of proteinsenzymesgenestumorsbioinformatics and drug efficacy; downloadable software for scientificmedicalhealthcarepharmaceutical and biotechnology analysissoftware for the identificationcataloguingcharacterizing and analysis of data relating to proteinsenzymesgenestumorsbioinformatics and drug efficacy

Classe 42

Scientific and technological services and research and design relating theretoresearch services in the field of proteinenzymegene and tumor analysisdesign of research programmes and studies relating to proteinenzymegene and tumor analysis; medical research; medical developmentmedicine development services; pharmaceutical and biotechnology research and development; design and development of computer software; providing temporary use of onlinenon-downloadable software for the identificationcataloguingcharacterizing and analysis of data relating to proteinsenzymesgenestumorsbioinformatics and drug efficacy; proteomicsmedical and scientific research in the field of proteomes; kinase profiling and screening in the nature of testing of enzymes for scientific and medical research purposes; biomarker profiling and screening in the nature of testing of naturally occurring moleculesgenescharacteristics in the human body for scientific and medical research purposes; tumor testing and profilingdiagnostic tests in the field of tumor identification and analysis for medical research purposes; gene expression profiling and analysis for medical research purposes; sequencing DNA and analysis for medical research purposes; genotyping for medical research and analysis purposes; contract scientificmedicalpharmaceutical and biotechnology research and laboratory services; providing an onlinesearchable database featuring medical research data relating to the identificationcataloguingcharacterizing and analysis of proteinsenzymesgenestumorsbioinformatics and drug efficacy; providing temporary use of onlinenon-downloadable software for scientificmedicalhealthcarepharmaceutical and biotechnology analysissoftware for the identificationcataloguingcharacterizing and analysis of data relating to proteinsenzymesgenestumorsbioinformatics and drug efficacy

Classe 44

Medical services; healthcare services; medical screening; medical diagnostic services; providing an onlinesearchable database featuring data relating to the identificationcataloguingcharacterizing and analysis of proteinsenzymesgenestumorsbioinformatics and drug efficacy; tumor testing and profilingtumor DNA sequencing and analysis for medical diagnostic purposes; gene expression profiling for medical diagnostic purposes; sequencing DNA for medical diagnostic purposes; tumor testing and profilingmedical testing in the field of tumor identificationanalysis and treatment; tumor testing and profilingdiagnostic testing in the field of tumor treatment; gene expression profiling for medical diagnostic analysis purposes; sequencing DNA for medical diagnostic analysis purposes; providing an onlinesearchable database featuring patient data used in the treatment of individuals relating to the identificationcataloguingcharacterizing and analysis of proteinsenzymesgenestumorsbioinformatics and drug efficacy

Classe 45

Licensing of intellectual property

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

15/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

15/09/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

20/08/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/08/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

20/08/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/06/2020

PUBO

PUBLISHED FOR OPPOSITION

30/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/06/2020

EXPT

EXPARTE APPEAL TERMINATED

23/05/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/05/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

20/05/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

20/05/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

20/05/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

20/05/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/05/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

14/05/2020

ALIE

ASSIGNED TO LIE

13/05/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/05/2020

EXPI

EX PARTE APPEAL-INSTITUTED

10/05/2020

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

10/05/2020

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

10/05/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

13/11/2019

GNFR

FINAL REFUSAL E-MAILED

13/11/2019

CNFR

FINAL REFUSAL WRITTEN

13/11/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/10/2019

ALIE

ASSIGNED TO LIE

11/10/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

07/10/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/10/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/10/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/04/2019

GNRT

NON-FINAL ACTION E-MAILED

05/04/2019

CNRT

NON-FINAL ACTION WRITTEN

05/04/2019

DOCK

ASSIGNED TO EXAMINER

04/04/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

14/02/2019

NWAP

NEW APPLICATION ENTERED

26/01/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace KINOMICA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.